Matthew E Korenberg Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Matthew E Korenberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Matthew E Korenberg. Matthew E Korenberg is a EVP,Finance & Strategy and CFO in LIGAND PHARMACEUTICALS INC ($LGND) and a VP, Finance and CFO in LIGAND PHARMACEUTICALS INC ($LGND) and a Director in Qualigen Therapeutics, Inc. ($RTTR).
Address: 11119 NORTH TORREY PINES ROAD, SUITE 200 LA JOLLA 92037 CA
Companies in which Matthew E Korenberg is an Insider
LIGAND PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew E Korenberg: EVP,Finance & Strategy and CFO, VP, Finance and CFO
Holdings: 41,752 shares
Current Value: $4,502,536
Latest Transaction: Feb 05 2021
$LGND Market Capitalization: $2.24B
$LGND Previous Close: $107.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Qualigen Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew E Korenberg: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 08 2020
$RTTR Market Capitalization: $36.80M
$RTTR Previous Close: $3.44
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Matthew E Korenberg
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Option Exercise | A | 177.50 | 11,591 | 2,057,403 | 11,591 | |
| Feb 05 2021 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Grant | A | 0.00 | 10,819 | 0 | 41,752 | 30.9 K to 41.8 K (+34.98 %) |
| Jan 27 2021 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Payment of Exercise | F | 156.01 | 1,440 | 224,654 | 30,933 | 32.4 K to 30.9 K (-4.45 %) |
| Jan 27 2021 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Grant | A | 0.00 | 4,803 | 0 | 32,373 | 27.6 K to 32.4 K (+17.42 %) |
| Jan 27 2021 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Payment of Exercise | F | 156.01 | 671 | 104,683 | 27,570 | 28.2 K to 27.6 K (-2.38 %) |
| Jan 27 2021 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Grant | A | 0.00 | 2,305 | 0 | 28,241 | 25.9 K to 28.2 K (+8.89 %) |
| Jul 01 2020 | LGND | LIGAND PHARMACEUTI ... | Korenberg Matthew E | EVP,Finance & Strat ... | Buy | J | 89.03 | 238 | 21,189 | 25,936 | 25.7 K to 25.9 K (+0.93 %) |